TScan Therapeutics (TCRX) Other Non-Current Assets (2020 - 2026)
TScan Therapeutics (TCRX) recorded Other Non-Current Assets of $5.03 million in Q2 2026, unchanged from $5.03 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
TScan Therapeutics (TCRX) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Starting with Q4 2020, TScan Therapeutics' Other Non-Current Assets history includes 23 quarters.
- Annual Other Non-Current Assets has a five-year compound annual growth rate of 53.3% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $5.03 million in FY2024 (unchanged), $5.03 million in FY2023 (-0.1%), $5.04 million in FY2022 (+0.1%) and $5.03 million in FY2021 (+745.5%).
- Quarterly Other Non-Current Assets has ranged from $595,000 in Q3 2021 to $5.04 million in Q4 2022 over the past five years.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 746.6% in Q3 2022, against a decline of 0.1% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.03 million (Q1 2026), $5.03 million (Q4 2025) and $5.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 9.94 Bn |
| 10 | TScan Therapeutics | 26.76 Mn | -538.36 Mn | - | 5.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.08 Mn |
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 5.13 Mn |
| Sep 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 5.03 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Sep 30, 2024 | 5.03 Mn |
| Jun 30, 2024 | 5.03 Mn |
| Mar 31, 2024 | 5.03 Mn |
| Dec 31, 2023 | 6.68 Mn |
| Sep 30, 2023 | 5.03 Mn |
| Jun 30, 2023 | 5.03 Mn |
| Mar 31, 2023 | 5.03 Mn |
| Dec 31, 2022 | 5.76 Mn |
| Sep 30, 2022 | 5.04 Mn |
| Jun 30, 2022 | 5.04 Mn |
| Mar 31, 2022 | 5.03 Mn |
| Dec 31, 2021 | 5.20 Mn |
| Sep 30, 2021 | 595,000.00 |
API Access
TScan Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();